Effect of Allopurinol Treatment on Insulin Resistance
NCT02008968
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
130
Enrollment
OTHER
Sponsor class
Conditions
Hyperuricemia
Prediabetes
Insulin Resistance
Interventions
DRUG:
allopurinol 300 mg./day
OTHER:
No intervention
DRUG:
Normouricemic
Sponsor
Istanbul Medeniyet University